Less is more in the case of this cancer treatment. The most common form of cancer among men in the US, after skin cancer, ...

A landmark £42 million trial aimed at revolutionising prostate cancer screening has officially begun in the UK, with the first eligible men now invited to participate. Health Secretary Wes Streeting ...

Approximately one in eight American men will be diagnosed with prostate cancer during their lifetime. For most of them, if ...

Over half of patients in a randomized trial switch from enzalutamide to darolutamide because of cognitive issues; no one switches in the opposite direction.

Darolutamide offers "an option for preserving cognitive health" in advanced disease, exper ...

A recent post hoc analysis assesses whether PSA changes can predict survival outcomes in patients with metastatic or very high risk nonmetastatic prostate cancer.

Ceramides-lipid molecules in cells that affect many physiological functions including cell differentiation, migration, and ...

A new experimental drug is showing potential in treating prostate cancer and possibly other forms of the disease. A new immunotherapy drug used in a prostate cancer clinical trial is showing early ...

A new blood test could help doctors identify whether a treatment for advanced prostate cancer is failing weeks earlier than ...

Prostate cancer is the most commonly diagnosed cancer in the UK, with more than 63,000 new cases each year. Yet for many men, understanding their treatment options remains far from straightforward ...

A proof-of-concept study has created a blueprint for producing prostate cancer treatment more efficiently. Researchers at the ...